advertisement
Lascaratos G 35
Showing records 1 to 25 | Display only abstracts from Lascaratos G in IGR 25-1120564 Peripheral blood mononuclear cell respiratory function is associated with progressive glaucomatous vision loss
Petriti B; Rabiolo A; Chau KY; Williams PA; Montesano G; Lascaratos G; Garway-Heath DF
Nature Medicine 2024; 30: 2362-2370 (IGR: 25-1)
110051 The Role of Mitophagy in Glaucomatous Neurodegeneration
Stavropoulos D; Grewal MK; Petriti B; Chau KY; Hammond CJ; Garway-Heath DF; Lascaratos G
Cells 2023; 12: (IGR: 24-1/2)
106457 Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom
Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S
Ophthalmology. Glaucoma 2023; 6: 342-357 (IGR: 23-3)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Tanner A
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Magan T
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Haddad F
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Tanner A; Fajardo-Sanchez J
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Fajardo-Sanchez J
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Fajardo-Sanchez J
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Fajardo-Sanchez J
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Lim KS
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Nguyen E
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Goyal S
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Thong KX; Ah-Moye S
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Rodrigues I; Amaya L
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Perl N; Abu-Bakra M
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Trikha S; Kulkarni A
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Kulkarni A; Trikha S
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Hammond C
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Lascaratos G
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
98478 Long-term outcomes in Primary congenital glaucoma, aniridia and anterior segment dysgenesis
Lascaratos G; Yu-Wai-Man C
European Journal of Ophthalmology 2022; 0: 11206721211073208 (IGR: 22-4)
99335 One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis
Parnell M; Kailani O; King AJ; Agrawal P; Stead R; Giannouladis K; Rodrigues I; Goyal S; Hysi PG; Lim S; Yu-Wai-Man C
British Journal of Ophthalmology 2023; 107: 1104-1111 (IGR: 22-4)
94852 Neuroprotection in Glaucoma: NAD/NADH Redox State as a Potential Biomarker and Therapeutic Target
Petriti B; Williams PA; Lascaratos G; Chau KY; Garway-Heath DF
Cells 2021; 10: (IGR: 22-2)
73063 Systemic PTEN-Akt1-mTOR pathway activity in patients with normal tension glaucoma and ocular hypertension: A case series
Lascaratos G; Chau KY; Zhu H; Gkotsi D; Kamal D; Gout I; Luthert PJ; Schapira AHV; Garway-Heath DF
Mitochondrion 2017; 36: 96-102 (IGR: 18-4)
61413 Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Lascaratos G; Chau KY; Zhu H; Gkotsi D; King R; Gout I; Kamal D; Luthert PJ; Schapira AH; Garway-Heath DF
Neurobiology of Disease 2015; 82: 78-85 (IGR: 17-1)
